Skip to Content

Pacer BioThreat Strategy ETF VIRS

Medalist Rating as of | See Pacer Investment Hub

Morningstar’s Analysis VIRS

Will VIRS outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Pacer BioThreat Strategy ETF retains its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VIRS

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 52.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

NVIDIA Corp

8.27 298,174
Technology

Netflix Inc

5.60 202,082
Communication Services

Walmart Inc

5.31 191,326
Consumer Defensive

Merck & Co Inc

5.26 189,645
Healthcare

Amazon.com Inc

5.19 187,119
Consumer Cyclical

Thermo Fisher Scientific Inc

5.08 183,325
Healthcare

Danaher Corp

5.08 183,004
Healthcare

Lowe's Companies Inc

4.47 161,188
Consumer Cyclical

The Home Depot Inc

4.37 157,656
Consumer Cyclical

Abbott Laboratories

4.18 150,803
Healthcare